CN1058156C - Osteophytosis pill and its compounding method - Google Patents
Osteophytosis pill and its compounding method Download PDFInfo
- Publication number
- CN1058156C CN1058156C CN96118666A CN96118666A CN1058156C CN 1058156 C CN1058156 C CN 1058156C CN 96118666 A CN96118666 A CN 96118666A CN 96118666 A CN96118666 A CN 96118666A CN 1058156 C CN1058156 C CN 1058156C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- herba
- pill
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006187 pill Substances 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims description 12
- 201000010934 exostosis Diseases 0.000 title abstract 5
- 238000013329 compounding Methods 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 36
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 3
- 206010005963 Bone formation increased Diseases 0.000 claims description 23
- 241000005787 Cistanche Species 0.000 claims description 6
- 239000004863 Frankincense Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 241000255791 Bombyx Species 0.000 claims description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241000903946 Clematidis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 241000283956 Manis Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 208000024891 symptom Diseases 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 3
- 241000402754 Erythranthe moschata Species 0.000 abstract 2
- 235000012907 honey Nutrition 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 206010020880 Hypertrophy Diseases 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 8
- 208000037920 primary disease Diseases 0.000 description 7
- 244000153234 Hibiscus abelmoschus Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000002805 bone matrix Anatomy 0.000 description 2
- 208000036319 cervical spondylosis Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000005801 spondylosis Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241000427159 Achyranthes Species 0.000 description 1
- 208000013824 Acidemia Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000601164 Clematis orientalis Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001148782 Davallia Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000123589 Dipsacus Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000212321 Levisticum Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 241000488974 Loranthus Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 241000521581 Millettia Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000736246 Pyrola Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004749 ligamentum flavum Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an osteophytosis pill and a preparation method thereof. The osteophytosis pill is prepared from 42 kinds of traditional Chinese medicines comprising angelica, prepared rhizome of rehmannia, yam, stir-fried ovate atractylodes root, etc. The preparation method comprises: the yam bran and the stir-fried ovate atractylodes root are crushed into fine powders and are sieved for use; the residues of the yam bran and the stir-fried ovate atractylodes root are decocted twice with the other 39 kinds of medicines except musk; the decocted juices obtained in the two times are mixed and filtered; the filtrate is concentrated into a thick ointment; the thick ointment is evenly mixed with the fine powders; the mixture is dried, crushed and sieved; musk and refined honey are added to the mixture; and big honeyed pills are obtained by rubbing the mixture of warm honey and medicine. The osteophytosis pill has the function of treatment on both the symptoms and root causes of osteophytosis, and has no toxic or side effect.
Description
The present invention relates to a kind of Chinese medicine and compound method thereof, particularly a kind of pill and compound method thereof of eliminating and suppressing hyperosteogeny.
At present, both at home and abroad medical circle is for the also satisfied without comparison medicine of the treatment of hyperosteogeny, because primary disease is a kind ofly to suffer sclerotin degenerative disease due to the chronic injury by bone or articular cartilage degeneration and joint.Clinical bone joint pain, swelling, discomfort, the limitation of activity of mainly showing as.The traditional Chinese medical science thinks that primary disease belongs to the category of " migratory arthralgia " " arthralgia due to cold " " arthralgia chiefly caused by damp pathogen ".Modern medicine is thought: with advancing age, degeneration little by little takes place in human intervertebral disc, fibre board elastic force goes down, intervertebral disc is outstanding to all around, the intervertebral space stenosis is narrow, vertebral rim hypertrophy, intervertebral instability, the Secondary cases in hypertrophy of ligamentum flavum, degeneration, unciform process joint hyperplasia and little joint change and form.The traditional Chinese medical science is thought the generation of primary disease, how because of the kidney qi decline, overworks, and " wind, cold, wet " is rich mutually, sends out and is due to the numbness, and it is dirty to relate generally to kidney,spleen,liver three.
Treatment to primary disease, the Western medicine choice drug is " sodium salicylate " each 1.5-2g at present, three (list of references " the clinical handbook of practical combination of Chinese and Western medicine Xueyuan Press publication every day, in August, 1989), but this medicine can not effect a radical cure primary disease, and have very strong toxic and side effects, as occur feeling sick, digestive tract irritation such as vomiting, can cause gastrorrhagia.The clothes heavy dose also can make thrombinogen reduce and cause the systemic bleeding tendency for a long time, headache, dizzy, tinnitus, audiovisual power go down, abalienation, collapse, stupor, acidemia etc. can appear in severe patient, and anaphylaxiss such as erythra, nervus vasculairs edema, asthma can occur.Dosage is big more, the course of treatment is long more, and how obvious above-mentioned side effect is.Chinese medicine is " Decoction of Notopterygium for Rheumatism " (list of references " pharmacology of Chinese medical formulae " to the treatment of primary disease side commonly used, high medical college teaching material, Shanghai science tech publishing house publishes, in April, 1993), add to simplify with this side and cut out the treatment primary disease and still can not reach satisfactory effect, this side just in the Wei Liangxu of battalion, wind, cold, wet sanction utilization when being detained meridians, has the effect of supplementing QI to normalize nutrient QI, expelling wind and dampness, often so and delay treatment.
The objective of the invention is to overcome the shortcoming of above-mentioned prior art, proposed a kind of pill that effects a radical cure hyperosteogeny---hypertrophy ball and compound method thereof, be characterized in that this medicine is pure Chinese medicinal preparation, without any side effects, strengthening vital QI to eliminate pathogenic factors, treating both the principal and the secondary aspects of a disease at the same time has blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, kidney tonifying is strengthened muscle, suppress and eliminate the effect of hyperosteogeny, make and set upright and help eliminating evilly, heresy is gone and is not hindered, among the kidney tonifying spleen invigorating with soothing liver-QI, make eutopic reduction and do not have the worry of the stagnation of QI, in eliminating evil, hold concurrently, heresy is gone and do not have a fraud of the stasis of blood of staying with blood circulation promoting and blood stasis dispelling, to the bone matrix hyperplasia treating both the principal and the secondary aspects of a disease at the same time, have good effect, late result is particularly remarkable, can fully recover and more back nothing recurrence.
Prescription of the present invention is a monarch drug with Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Radix Paeoniae Alba, Fructus Corni, Fructus Lycii, is ministerial drug with Sanguis Draxonis, Semen Persicae, Flos Carthami, Radix Salviae Miltiorrhizae, Olibanum, Myrrha, Rhizoma Gastrodiae, Squama Manis, Herba Pyrolae, Moschus, Radix Angelicae Pubescentis, Radix Clematidis, Caulis Spatholobi, Herba Taxilli, Bombyx Batryticatus, Fructus Chaenomelis, Pheretima; With Carapax et Plastrum Testudinis, Carapax Trionycis, Radix Dipsaci, the Cortex Eucommiae, the Radix Astragali, to process the five tastes, Rhizoma Cibotii, Rhizoma Curculiginis, Ba Zhantian, Herba Cistanches, Rhizoma Drynariae, Herba Epimedii, Rhizoma Dioscoreae, Rhizoma Atractylodis Macrocephalae (parched) be adjuvant drug; With Radix Puerariae, the Radix Angelicae Dahuricae, Radix Achyranthis Bidentatae, Fructus Jujubae, the various medicine content of Radix Glycyrrhizae Preparata is messenger drug. are respectively: the stiff silkworm 1-3% of Radix Angelicae Sinensis 1-3% cultivated land 2-5% Ligusticum wallichii 1-3% Hangzhoupro Chinese herbaceous peony 1-3% cornus officinalis sieb et zucc 1-3% fruit of Chinese wolfberry 1-3% dragon's blood 0.3-2% peach kernel 1-3% safflower 1-3% red sage root 3-5% frankincense 1-3% myrrh 1-3% rhizoma Gastrodiae 1-3% pangolin 1-3% pyrola 1-3% Moschus 0.01-0.2% levisticum 1-3% root of Chinese clematis 3-5% reticulate millettia 3-5% parasitic loranthus 2-4% pawpaw 3-5% earthworm 1-3% tortoiseshell 1-3% turtle shell 1-3% teasel root 1-3% bark of eucommia 1-3% Radix Astragali 3-5% processs five tastes 1-3% rhizoma cibotii 1-3% thizoma curculiginis 1-3% bar war day 1-3% saline cistanche 1-3% rhizome of davallia 1-3% barrenwort 1-3% Chinese yam 14-20% rhizoma atractylodis macrocephalae 10-15% root of kudzu vine 1-3% root of Dahurain angelica 0.5-2% root of bidentate achyranthes 1-3% date 1-3% honey-fried licorice root 0.5-2%
Most preferred embodiment percentage ratio: Radix Angelicae Sinensis 1.76; Radix Rehmanniae Preparata 3.51; The Radix Paeoniae Alba 1.76; Rhizoma Chuanxiong 1.41; Semen Persicae 1.17; Flos Carthami 1.17; Squama Manis 1.05; Sanguis Draxonis 0.70; Pheretima 1.17; Bombyx Batryticatus 1.17; Olibanum 1.17; Myrrha 1.17; Caulis Spatholobi 3.51; Rhizoma Gastrodiae 1.17; Fructus Chaenomelis 3.51; Radix Salviae Miltiorrhizae 3.51; Herba Taxilli 3.51; Radix Angelicae Pubescentis 1.76; Radix Clematidis 3.51; The Radix Astragali 3.51; Process the five tastes 1.76; Fructus Corni 1.76; Fructus Lycii 1.76; Radix Dipsaci 1.76; Rhizoma Cibotii 1.76; The Cortex Eucommiae 1.76; Rhizoma Curculiginis 1.76; Crust war sky 2.34; Carapax et Plastrum Testudinis 1.17; Carapax Trionycis 1.17; Moschus 0.06; Herba Cistanches 1.76; Herba Pyrolae 1.76; Rhizoma Drynariae 2.34; Herba Epimedii 2.34; Rhizoma Dioscoreae 14.06; Rhizoma Atractylodis Macrocephalae (parched) 14.06; Radix Puerariae 1.05; The Radix Angelicae Dahuricae 0.70; Radix Achyranthis Bidentatae 1.76; Fructus Jujubae 1.17; Radix Glycyrrhizae Preparata 0.70.
Technology of the present invention is as follows:
With above 42 flavor medicines, take out in proportion.The Rhizoma Dioscoreae Rhizoma Atractylodis Macrocephalae (parched with bran) is ground into fine powder, sieving for standby, recrement and other the 39 flavor medicine except that Moschus decoct with water twice, each about 2～4 hours, after collecting decoction, the filtration, relative density was approximately 1.27～1.30 when filtrate was condensed into thick paste＜80 ℃〉with above-mentioned medicated powder mix homogeneously, dry, pulverize, sieve, add Moschus, refining Mel, make big close ball with warm driving fit medicine raft, promptly.
The present invention aims at bone matrix hyperplasia and establishes.With advancing age, the spleen insufficiency of blood, kidney qi fails gradually, when the kidney tonifying of enriching blood, so put down with Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Radix Paeoniae Alba, Fructus Corni, the sweet of Fructus Lycii, to enrich blood, to transfer blood, kidney tonifying, make " the kidney being the origin of congenital constitution " main to some extent, " the spleen being the foundation of acquired constitution ", spleen blood biochemistry is infinite, is monarch drug so choose Six-element.Wind, cold, wet, heresy is rich mutually, when eliminating evil, so with Pheretima, Fructus Chaenomelis, Herba Taxilli, Rhizoma Gastrodiae, Radix Angelicae Pubescentis, Radix Clematidis, Moschus expelling wind and dampness, dispersing cold for relieving pain, dredge the meridian passage.Disease then becomes the stasis of blood for a long time, and blood fortune is not smooth, the passages through which vital energy circulates stagnation of QI and blood may bring about pain, it is unfavorable that the joint song is stretched, and then need be equipped with blood circulation promoting and blood stasis dispelling among eliminating evil, so with Sanguis Draxonis, Semen Persicae, Flos Carthami, Herba Pyrolae, Caulis Spatholobi, Bombyx Batryticatus, Radix Salviae Miltiorrhizae, Olibanum, Myrrha, Squama Manis promoting blood circulation, removing blood stasis and relieving pain go heresy and do not stay the stasis of blood, so be ministerial drug.Though evil going, though pain end and can not eradicate, so with Carapax et Plastrum Testudinis, Carapax Trionycis, Radix Dipsaci, Du stretch, Rhizoma Cibotii, Rhizoma Curculiginis, Ba Zhantian, Herba Cistanches, Rhizoma Drynariae, Herba Epimedii, Rhizoma Dioscoreae, Rhizoma Atractylodis Macrocephalae (parched) assist monarch drug, spleen invigorating helps fortune, the hemopoietic of enriching blood, kidney tonifying are strengthened muscle, so be adjuvant drug.Radix Puerariae, that the Radix Angelicae Dahuricae draws blood is up, the Radix Achyranthis Bidentatae conducting blood to flow downwards, and Fructus Jujubae, Radix Glycyrrhizae Preparata coordinating the actions of various ingredients in a prescription are strengthened the through sick institute of all medicines.Full side 42 flavor medicines share, and become blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, hard masses softening and resolving, easing the affected liver, spleen invigorating, kidney tonifying altogether.Make and set upright and favourable eliminating evil, heresy is gone and is not just hindered, and with soothing liver-QI, makes eutopic reduction and does not have a worry of the stagnation of QI among the kidney tonifying spleen invigorating, holds concurrently among eliminating evil and reduces phlegm with dissipating blood stasis, heresy is gone and does not have the fraud of the stasis of blood of staying, and reaches the effect that suppresses and eliminate for hyperosteogeny.
The present invention has carried out 384 example experiments altogether, and all cases are all checked through film making of X line or MRI, are diagnosed as hyperosteogeny in conjunction with clinical symptoms.Hyperosteogeny of cervical vertebra 288 examples wherein, lumbar vertebra hyperosteogeny 40 examples, knee joint hyperosteogeny 16 examples, hyperosteogeny 4 examples, merge hyperosteogeny 36 examples, male 194 examples, women 190 examples, oldest 80 years old, 28 years old of age minimum, the more than two decades that the course of disease is the longest, the shortest two months.
Criterion of therapeutical effect: (one) clinical cure: treat transference cures such as the back is lopsided corrects, sour, numb, as to swell and ache, functional rehabilitation is normal, does not have more than 2 years and recurs; (2) produce effects: treatment back deformity is basic corrects, and symptoms such as acid, fiber crops, swollen, pain disappear substantially, and function is recovered substantially; (3) effective: treatment back deformity is corrected to some extent, and symptoms such as acid, fiber crops, swollen, pain have the part disappearance, and function is recovered to some extent; (4) invalid: all are with before treating.A) hyperosteogeny of cervical vertebra totally 288 examples: clinical cure 278 examples, produce effects 10 examples, effective 0 example, invalid 0 example.B) lumbar vertebra hyperosteogeny totally 40 examples: clinical cure 32 examples, produce effects 4 examples, effective 2 examples, invalid 2 examples.C) knee joint hyperosteogeny totally 16 examples: clinical cure 12 examples, produce effects 2 examples, effective 1 example, invalid 1 example.D) hyperosteogeny totally 4 examples: clinical cure 2 examples, produce effects 1 example, effective 0 example, invalid 1 example.E) merge hyperosteogeny 36 examples: clinical cure 30 examples, produce effects 4 examples, effective 2 examples, invalid 0 example.
Therapeutic outcome: clinical recovery 354 examples, produce effects 21 examples, effective 5 examples, invalid 4 examples, total effective rate is 98%, cure rate is 92%.
Typical case's medical record is given an example:
The field, the man, 52 years old, 90 years conscious cervical regions, back, shoulder pain, pain to arm and finger radiation and with headache, dizzy, feel sick, symptoms such as vomiting, tinnitus, numbness of hand.The big First Academy checks in doctor trained in Western medicine, and X line film making prompting: (1) neck 4.5 right side unciform process hypertrophy hypertrophys, corresponding intervertebral foramina diminish; (2) ligamentum nuchae ossification.MRI checks suggestion: (1) neck 3,4,5 hyperosteogenys; (2) neck 5-6 intervertebral disk hernia.Be diagnosed as cervical spondylosis (spiritual root type merges vertebral artery type).This patient's state of an illness is heavier, once is in hospital several times, oral in, treatment such as Western medicine, physical therapy, massage, medicine external application, Hyperbaric oxygen chamber all do not have obvious curative effects.Adopted the hypertrophy pill for curing in 92 years, and received produce effects after 2 courses of treatment, above-mentioned symptom disappears substantially, and recovery from illness can be driven motorcycle and be gone at express speed after 70 days.Adhere to taking medicine 5 courses of treatment, do not have recurrence in 4 years subsequently so far.
Chen, the woman, 80 years old, found the cervical pain discomfort in 91 years, dizziness, myasthenia of limbs has " stepping on the Cotton Gossypii sensation " during walking, and the centre of body weight shakiness is easily fallen down, and can not keep straight on.Point out at the doctor trained in Western medicine X of big First Academy ray examination: neck 3,4,5 hypertrophy are diagnosed as cervical spondylosis (myeloid form).Take the hypertrophy ball, above-mentioned symptom disappears substantially after two courses of treatment, takes recovery from illness 5 courses of treatment continuously, does not have recurrence so far.
Section certain, the man 48 years old, suffers from hyperosteogeny for many years, X sheet inspection prompting, the serious hypertrophy of lumbar vertebra, L
3-L
4Between this formation of bone abutment, waist is ached, numbness of lower limbs is unable, through curing no produce effects in many ways.Took the hypertrophy ball in 94 years, receive produce effects after the course of treatment, above-mentioned symptom disappears substantially, adheres to 5 courses of treatment of medication, and recovery from illness does not have recurrence so far.
The Wang, the man, 80 years old, double knee joint swelled and ache unbearable, and friction sound, stiff, limitation of activity, difficulty in walking are arranged, and only can hold up dolly to move one's steps surplus in the of ten year on ordinary days.The inspection of X sheet is as seen: hyperosteogeny forms, and the joint space narrows down, has episome, synovial membrane edema, is diagnosed as the hypertrophy gonarthritis.Very good with effect behind the hypertrophy pill for curing, take medicine and just felt pain relief in back second day, but sustaining wall walking in the 3rd day.Above-mentioned symptom disappears substantially after two courses of treatment, adheres to 5 courses of treatment of medication, and recovery from illness is recurrence so far.
Claims (3)
1, Chinese pill for curing hyperosteogeny is characterized in that, it is to be made by following raw materials by weight percent:
Radix Angelicae Sinensis 1-3% Radix Rehmanniae Preparata 2-5% Rhizoma Chuanxiong 1-3% Radix Paeoniae Alba 1-3%
Fructus Corni 1-3% Fructus Lycii 1-3% Sanguis Draxonis 0.3-2% Semen Persicae 1-3%
Flos Carthami 1-3% Radix Salviae Miltiorrhizae 3-5% Olibanum 1-3% Myrrha 1-3%
Rhizoma Gastrodiae 1-3% Squama Manis 1-3% Herba Pyrolae 1-3% Moschus 0.01-0.2
Radix Angelicae Pubescentis 1-3% Radix Clematidis 3-5% Caulis Spatholobi 3-5% Herba Taxilli 2-4%
Bombyx Batryticatus 1-3% Fructus Chaenomelis 3-5% Pheretima 1-3% Carapax et Plastrum Testudinis 1-3%
Carapax Trionycis 1-3% Radix Dipsaci 1-3% Cortex Eucommiae 1-3% Radix Astragali 3-5%
Process five tastes 1-3% Rhizoma Cibotii 1-3% Rhizoma Curculiginis 1-3% crust halberd and vow 1-3%
Herba Cistanches 1-3% Rhizoma Drynariae 1-3% Herba Epimedii 1-3% Rhizoma Dioscoreae 14-20%
Rhizoma Atractylodis Macrocephalae (parched) 10-15% Radix Puerariae 1-3% Radix Angelicae Dahuricae 0.5-2% Radix Achyranthis Bidentatae 1-3%
Fructus Jujubae 1-3% Radix Glycyrrhizae Preparata 0.5-2%.
2, Chinese pill for curing hyperosteogeny according to claim 1, it is characterized in that the percentage ratio of said material composition is: Radix Angelicae Sinensis 1.76, Radix Rehmanniae Preparata 3.51, the Radix Paeoniae Alba 1.76, Rhizoma Chuanxiong 1.41, Semen Persicae 1.17, Flos Carthami 1.17, Squama Manis 1.05, Sanguis Draxonis 0.70, Pheretima 1.17, Bombyx Batryticatus 1.17, Olibanum 1.17, Myrrha 1.17, Caulis Spatholobi 3.51, Rhizoma Gastrodiae 1.17, Fructus Chaenomelis 3.51, Radix Salviae Miltiorrhizae 3.51, Herba Taxilli 3.51, Radix Angelicae Pubescentis 1.76, Radix Clematidis 3.51, the Radix Astragali 3.51 is processed the five tastes 1.76, Fructus Corni 1.76, Fructus Lycii 1.76, Radix Dipsaci 1.76, Rhizoma Cibotii 1.76, the Cortex Eucommiae 1.76, Rhizoma Curculiginis 1.76, Radix Morindae Officinalis 2.34, Carapax et Plastrum Testudinis 1.17, Carapax Trionycis 1.17, Moschus 0.06, Herba Cistanches 1.76, Herba Pyrolae 1.76, Rhizoma Drynariae 2.34, Herba Epimedii 2.34, Rhizoma Dioscoreae 14.06, Rhizoma Atractylodis Macrocephalae (parched) 14.06, Radix Puerariae 1.05, the Radix Angelicae Dahuricae 0.70, Radix Achyranthis Bidentatae 1.76, Fructus Jujubae 1.17, Radix Glycyrrhizae Preparata 0.70.
3, a kind of method of preparing Chinese pill for curing hyperosteogeny as claimed in claim 1 or 2 is characterized in that, at first with above 42 flavor medicines, take out in proportion, it is standby that the Rhizoma Dioscoreae Rhizoma Atractylodis Macrocephalae (parched with bran) is ground into fine powder ， Guo Sieve, recrement and other the 39 flavor medicine except that Moschus decoct with water twice, each about 2-4 hour, after collecting decoction, the filtration, filtrate was condensed into thick paste and above-mentioned medicated powder mix homogeneously, drying, pulverizing, Guo Sieve, adding Moschus, the refining Mel twists into big close ball with warm driving fit medicine, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96118666A CN1058156C (en) | 1996-04-18 | 1996-04-18 | Osteophytosis pill and its compounding method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96118666A CN1058156C (en) | 1996-04-18 | 1996-04-18 | Osteophytosis pill and its compounding method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1150910A CN1150910A (en) | 1997-06-04 |
| CN1058156C true CN1058156C (en) | 2000-11-08 |
Family
ID=5125237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96118666A Expired - Fee Related CN1058156C (en) | 1996-04-18 | 1996-04-18 | Osteophytosis pill and its compounding method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058156C (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079029C (en) * | 1999-04-10 | 2002-02-13 | 李毅 | Medical capsule for treating bone rheumatism and preparing process |
| CN1294922C (en) * | 2005-03-11 | 2007-01-17 | 陈根生 | Medicine for treating osteoporosis and improving bone fracture healing |
| CN100394969C (en) * | 2006-03-28 | 2008-06-18 | 扬子江药业集团有限公司 | Osteoporosis treating compound Chinese preparation and its preparing process |
| CN100402077C (en) * | 2006-08-16 | 2008-07-16 | 张乃功 | Medicinal composition for treating hyperosteogency |
| CN101040927B (en) * | 2007-04-19 | 2010-05-26 | 尹继君 | Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
| CN101190256B (en) * | 2007-05-16 | 2010-07-14 | 李仁安 | Chuanqisan for treating cervical spondylopathy and preparation method |
| CN101204436B (en) * | 2007-12-17 | 2010-06-09 | 张福 | Chinese patent medicine for curing hyperosteogeny in knee joint |
| CN101637591B (en) * | 2008-08-01 | 2011-05-11 | 梁振兴 | Medicinal composition with functions of strengthening tendons and bones and reviving joints and preparation method |
| CN101744895A (en) * | 2008-12-03 | 2010-06-23 | 李国强 | Medical preparation for treatment of rheumatism, lumbar vertebra disease and cervical spondylosis |
| CN101703662B (en) * | 2009-11-13 | 2011-04-06 | 秦中文 | Oral Chinese medicament for treating hyperosteogeny |
| CN102028887B (en) * | 2010-11-26 | 2012-03-28 | 张民 | Traditional Chinese medicine for treating hyperplasia of cervical vertebra |
| CN102286346B (en) * | 2011-08-10 | 2013-03-06 | 黄学敏 | Crocodile bone wine and production method thereof |
| CN102370688B (en) * | 2011-11-17 | 2018-04-27 | 中国中医科学院中医临床基础医学研究所 | A kind of compound Chinese medicinal preparation for treating osteoproliferation and preparation method thereof |
| CN102935156B (en) * | 2012-11-25 | 2014-04-16 | 李同生 | Pills for treating hyperostosis |
| CN102935163B (en) * | 2012-11-26 | 2016-07-13 | 李中成 | The Chinese medicine preparation for the treatment of hyperosteogeny |
| CN102961616A (en) * | 2012-12-19 | 2013-03-13 | 傅哲龙 | Chinese drug agentia for treating osteoproliferation |
| CN103272095A (en) * | 2013-06-07 | 2013-09-04 | 刘巧慧 | Dorsal disc prolapse treatment traditional Chinese medicine preparation and preparation method thereof |
| CN103463512B (en) * | 2013-08-30 | 2015-03-04 | 段寒 | Oral traditional Chinese medicine composition for treating lumbar intervertebral disc herniation, cervical intervertebral disc herniation and hyperosteogeny |
| CN103479840B (en) * | 2013-09-11 | 2015-06-03 | 洪天降 | Chinese herbal composition for treating cervical, lumbar and bone hyperplasia |
| CN103933298A (en) * | 2014-05-13 | 2014-07-23 | 张娟 | Traditional Chinese medicine for treating heel bony spur and preparation method thereof |
| CN104000933A (en) * | 2014-06-21 | 2014-08-27 | 徐显廷 | Traditional Chinese medicine oral liquid for treating osteoproliferation |
| CN104147580B (en) * | 2014-08-29 | 2017-10-24 | 桂林市艾康科技有限公司 | A kind of moxa stick for treating osteoproliferation |
| CN104208363A (en) * | 2014-09-23 | 2014-12-17 | 周敏 | Chinese medicinal composition for treating hyperostosis |
| CN105168758A (en) * | 2015-11-03 | 2015-12-23 | 孙熙 | Medicine for treating hyperostosis |
| CN106963915A (en) * | 2016-01-14 | 2017-07-21 | 董琴 | A kind of cure scapulohumeral periarthritis, the Chinese medicine preparation of cervical spondylopathy and preparation method |
| CN106922821A (en) * | 2017-05-03 | 2017-07-07 | 贵阳中医学院 | Pawpaw plant extraction liquid, fermented yoghourt and preparation method thereof |
| CN110279834A (en) * | 2019-06-24 | 2019-09-27 | 嵊州市王氏医疗器械有限公司 | A kind for the treatment of of arthritis, plaster of osteoproliferation and preparation method thereof |
-
1996
- 1996-04-18 CN CN96118666A patent/CN1058156C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《福建中医药》1992,23(6) 1992.6.30 蔡鸿章，白灵杜辛汤配合手法治疗骨质增生80例疗效观察 * |
| 《福建中医药》1992,23(6) 1992.6.30 蔡鸿章，白灵杜辛汤配合手法治疗骨质增生80例疗效观察;《辽宁中医杂志》1991,18(2) 1991.2.28 张玉平等，中药治疗骨质增生110例 * |
| 《辽宁中医杂志》1991,18(2) 1991.2.28 张玉平等，中药治疗骨质增生110例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1150910A (en) | 1997-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1058156C (en) | Osteophytosis pill and its compounding method | |
| CN101185718B (en) | Medicine for treating bone joint disease and its preparation method | |
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN101099839A (en) | External-applied traditional Chinese medicine bag and using method thereof | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN102048893B (en) | Traditional Chinese medicine composition for treating arthromyodynia | |
| CN101357198B (en) | Traditional Chinese medicine for treating cerebral thrombus | |
| CN102247458B (en) | Capsule for warming collaterals and relaxing tendons | |
| CN106334107A (en) | Traditional Chinese medicine eye drops and preparation method thereof | |
| CN102784208B (en) | Medicament for treating lumbar disc herniation and preparation method thereof | |
| CN100490880C (en) | A kind of traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN100352465C (en) | Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method | |
| CN101361874B (en) | Sinew and bone setting-up pellet and preparation method thereof | |
| CN106267098A (en) | A kind of can effective Chinese medicine composition treating gout and preparation method thereof | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN111265609A (en) | Traditional Chinese medicine composition for adjuvant treatment of true myopia and preparation method thereof | |
| CN102872287A (en) | Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof | |
| CN100581578C (en) | Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof | |
| CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin | |
| CN100482259C (en) | Chinese medicine for treating cervical spondylosis | |
| CN107261029A (en) | Chinese medicine composition for improving pain and preparation method thereof | |
| CN121466241A (en) | Plant combined extract for treating protrusion and bulging of intervertebral disc and preparation method thereof | |
| CN105213793A (en) | Cure mainly osteoporotic Chinese medicine composition and method for making | |
| CN105535562A (en) | Traditional Chinese medicine composition for treating hemiplegia and preparing method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |